Covaxin Phase 2/3 Clinical Trials For 2-18 Age Group Over, To Submit Data Next Week
New Delhi: Bharat Biotech has completed the Phase 2 and 3 clinical trials of coronavirus vaccine, Covaxin for use in the age group of 2 to 18 years and is expected to submit the data by next week to the DCGI.
According to the Chairman…